Fact-checked by Grok 2 weeks ago

Psychosurgery

Psychosurgery encompasses neurosurgical procedures designed to treat refractory psychiatric disorders by ablating or disconnecting specific brain regions or neural pathways implicated in aberrant mental states. Pioneered in the 1930s by Portuguese neurologist , who introduced prefrontal leucotomy—involving targeted lesions in the frontal lobes to sever connections between and subcortical structures—the technique aimed to alleviate severe symptoms of conditions like and unresponsive to other interventions. Moniz's work earned him the in or Medicine in 1949, recognizing its potential to provide relief in otherwise intractable cases, though subsequent widespread adoption, particularly and Watts' transorbital in the United States, involved over 40,000 procedures by the 1950s with variable outcomes including symptom reduction in some patients but frequent severe adverse effects such as , , and personality alteration. The practice's defining characteristics include its empirical basis in early observations of behavioral changes post-trauma to frontal regions, yet it became mired in due to inconsistent data, lack of rigorous controls in historical applications, and ethical lapses in patient selection and , often applied to institutionalized populations for behavioral control rather than therapeutic precision. Pharmacological advances, notably medications in the , rendered psychosurgery largely obsolete for broad use, as these offered reversible alternatives with superior risk-benefit profiles in most scenarios. Today, refined stereotactic techniques—such as anterior capsulotomy, cingulotomy, or subcaudate tractotomy—are reserved for highly selective cases of treatment-resistant obsessive-compulsive disorder (OCD) or major , employing imaging-guided to minimize and yielding response rates of 40-60% in specialized centers, though long-term data remain limited and procedures face ongoing scrutiny for irreversibility and potential over-reliance on subjective outcome measures. These modern iterations underscore psychosurgery's evolution from crude intervention to a niche, evidence-constrained option, balancing causal intervention on neural circuits against profound risks where causal mechanisms of psychiatric illness persist incompletely understood.

Definition and Principles

Conceptual Foundations

Psychosurgery rests on the foundational premise that severe psychiatric disorders arise from aberrant neural circuits, particularly those linking the to subcortical structures like the and , which sustain pathological thought patterns, , and behavioral maladaptations. This approach embodies a causal materialist view, positing that mental symptoms are direct manifestations of disrupted connectivity rather than solely environmental or abstract psychological factors, and that precise surgical disruption of these circuits can interrupt the underlying to yield therapeutic relief. The rationale draws from first observations of brain-behavior correlations, such as prehistoric trephination—evidenced in healed skulls from sites worldwide, including —likely intended to alleviate intracranial disturbances associated with or perceived demonic possession manifesting as . A pivotal empirical foundation emerged from 19th-century case studies, exemplified by Phineas Gage's 1848 tamping iron injury, which destroyed portions of his frontal lobes and resulted in marked shifts from responsible demeanor to impulsivity and profanity, demonstrating the prefrontal region's role in executive function and inhibition without obliterating basic cognition. This informed the hypothesis that controlled lesions could replicate beneficial aspects of such to manage intractable or . In 1935, neurophysiologist John Fulton's experiments on chimpanzees further solidified the concept: ablation of prefrontal areas reduced rage responses to frustration while preserving problem-solving abilities, suggesting selective disconnection could decouple emotional overactivity from higher reasoning. Building on these, Portuguese neurologist Egas Moniz introduced prefrontal leucotomy that same year, targeting tracts between the frontal lobes and to sever "circuits of thought" fixated in disorders like obsessive-compulsive states, based on the assumption that such severance would liberate patients from repetitive ideation without wholesale erasure. Moniz's innovation, performed initially via injection and later refined, encapsulated the core principle of psychosurgery: exploiting the brain's modular to modulate output via input alteration, prioritizing symptom alleviation in treatment-resistant cases amid limited pharmacological options. This framework influenced subsequent techniques, emphasizing targeted interruption over diffuse ablation to align with observed neural hierarchies.

Theoretical Mechanisms

Psychosurgery's theoretical mechanisms originated with Egas Moniz's 1935 prefrontal leucotomy, which posited that severing fibers connecting the to subcortical structures, including the , would interrupt the neural pathways responsible for fixating pathological ideas and emotions in psychiatric disorders like and anxiety . Moniz drew from experiments showing reduced agitation after similar disruptions, theorizing that such lesions prevented the upward propagation of morbid impulses from limbic regions to higher cortical areas, thereby restoring behavioral flexibility without broadly impairing intellect. This disconnection assumed symptoms arose from overactive cortico-thalamic loops, where ablation could normalize circuit dynamics by eliminating feedback sustaining delusions or compulsions. Subsequent elaborations by Walter Freeman and James Watts in the 1940s refined this to emphasize thalamocortical projections as regulators of emotional attached to ideation, proposing that lobotomy-induced severance diminished the affective intensity of distressing thoughts, converting into and enabling patients to disengage from maladaptive preoccupations. Their model, informed by early , viewed the frontal lobes as integrators of thalamic sensory-emotional inputs, with surgical transection reducing limbic overflow hypothesized to drive symptoms in intractable and . Empirical observations post-procedure, such as blunted and improved , were interpreted as evidence of causal interruption in these pathways, though later critiques highlighted the nonspecificity of outcomes, attributing to partial deafferentation rather than precise targeting. Modern psychosurgery shifted toward stereotactic targeting of limbic structures, grounded in circuit-level models of dysfunction identified via . For instance, anterior cingulotomy lesions the dorsal to disrupt hyperactive limbic-cortical networks implicated in error monitoring and compulsive behaviors, particularly in obsessive-compulsive disorder (OCD), where functional MRI reveals excessive connectivity in these regions sustaining intrusive thoughts. Similarly, capsulotomy ablates fibers in the ventral to interrupt cortico-striato-thalamo-cortical loops, a multicircuit framework positing OCD in dysregulated orbitofrontal-basal ganglia interactions that amplify habit formation and inhibitory deficits. These rationales emphasize causal specificity—lesions normalize oscillatory abnormalities and metabolic hyperactivity in targeted nodes—supported by preoperative imaging correlations with symptom severity, though long-term mechanisms remain partly opaque, blending ablation effects with potential neuroplastic reorganization.

Surgical Techniques

Early Invasive Methods

The origins of psychosurgery trace to the mid-1930s, when Portuguese neurologist Egas Moniz developed prefrontal leucotomy as an invasive surgical intervention targeting severe psychiatric disorders unresponsive to other treatments. On November 12, 1935, Moniz performed the first such procedure at Hospital de Santa Marta in on a patient with agitated depression, involving the injection of absolute alcohol into the subcortical of the frontal lobes to disrupt neural connections between the and deeper structures like the . Subsequent operations by Moniz and neurosurgeon Almeida Lima refined the technique, shifting from alcohol ablation—which risked unpredictable spread and tissue damage—to a mechanical : small burr holes were drilled bilaterally into the skull above the temples, through which a specialized with retractable wire loops was inserted and rotated to sever tracts, aiming to alleviate symptoms such as hallucinations and anxiety by interrupting frontal-subcortical pathways. These early leucotomies were highly invasive, requiring general and open cranial access, with procedures typically lasting 30-60 minutes per side and targeting roughly 3-4 cm deep into the frontal based on anatomical landmarks rather than precise imaging. Moniz reported initial success in reducing among 20 patients operated on between 1935 and 1936, though outcomes varied widely, with some exhibiting or as side effects of the broad fiber transection. The method's rationale stemmed from observations in animal ablation studies and human injuries, positing that severing inhibitory frontal influences could normalize subcortical hyperactivity in . In the United States, psychiatrist Walter Freeman and neurosurgeon James Watts adopted and modified Moniz's approach starting in 1936, performing open prefrontal lobotomies that involved larger craniotomies to access and excise or cut prefrontal white matter more extensively, often removing portions of the frontal cortex to ensure disconnection. Seeking to simplify the process for institutional use, Freeman introduced the transorbital lobotomy in 1946, a less invasive variant that bypassed skull drilling: an orbitoclast—a metal rod resembling an ice pick—was inserted under the upper eyelid, tapped with a mallet through the thin orbital plate into the frontal lobes, and then angled and swept laterally to sever thalamofrontal fibers bilaterally, completing the operation in under 10 minutes often under electroconvulsive anesthesia without sterile surgical suites. This technique, performed on thousands of patients by the early 1950s, prioritized speed and accessibility for non-neurosurgeons but increased risks of orbital infection, hemorrhage, and inconsistent lesion placement due to reliance on manual guidance. Early invasive psychosurgery methods like these represented a of gross anatomical disruption, contrasting with later stereotactic precision, and were applied to conditions including , , and intractable anxiety, with alone claiming over 3,500 transorbital procedures by 1967 despite mounting evidence of high complication rates such as (up to 15%) and mortality (around 2-5%). Empirical follow-up on Moniz's series indicated symptom relief in approximately 70% of cases but at the cost of diminished initiative and emotional blunting, underscoring the trade-offs of indiscriminate fiber sectioning without causal specificity to underlying pathologies.

Stereotactic and Targeted Approaches

Stereotactic approaches marked a significant advancement in psychosurgery by introducing targeting of subcortical structures using a skull-fixed to define Cartesian coordinates, guided initially by or ventriculography and later by computed and . Lesions are produced through methods such as radiofrequency thermocoagulation, which heats tissue via an inserted to create controlled , or radiosurgical techniques like Gamma Knife, delivering focused radiation beams. This , originating in the , minimized the extensive cortical damage of earlier lobotomies by confining interventions to specific fiber tracts or nuclei implicated in . Ernest Spiegel and Henry Wycis pioneered human stereotactic psychosurgery in 1947, adapting Horsley-Clarke apparatus for clinical use to lesion thalamic regions in psychiatric patients, thereby establishing the foundation for functional . Subsequent refinements included Jean Talairach's anterior capsulotomy in 1949, targeting the anterior limb of the to sever aberrant frontothalamic connections. These techniques emphasized empirical localization of "emotional circuits" based on anatomical and lesion-response correlations from animal models and early human cases. Key targeted procedures encompass:
  • Anterior cingulotomy: Involves bilateral lesions in the anterior cingulate gyrus via burr-hole access and thermocoagulation, as formalized by Herbert Ballantine in 1962, to disrupt visceromotor integration linked to anxiety and . Later iterations employed "six-pack" multi-lesion configurations for enhanced efficacy while preserving adjacent tissue.
  • Anterior capsulotomy: Ablates fibers in the anterior to interrupt orbitofrontal-thalamic loops, performed stereotactically since the late with probes guided to 20-25 mm anterior to the .
  • Subcaudate tractotomy: Targets ventral to the , lesioning frontolimbic projections to alleviate depressive symptoms, typically via implants or radiofrequency for tract severance.
  • Limbic leucotomy: Combines cingulotomy and subcaudate lesions to broadly modulate limbic-frontal interactions, introduced as a stereotactic hybrid in the for refractory cases.
Contemporary iterations incorporate frameless neuronavigation, diffusion tensor imaging for , and emerging non-incisional modalities like magnetic resonance-guided , which ablates targets transcranially without hardware penetration, as demonstrated in initial psychiatric applications since 2016. These evolutions prioritize causal disruption of dysregulated networks over indiscriminate resection, supported by intraoperative physiological verification via microelectrode recordings.

Ablative versus Modulatory Procedures

Ablative procedures in psychosurgery involve the intentional destruction of targeted to disrupt aberrant neural circuits implicated in psychiatric disorders, typically achieved through stereotactic techniques such as radiofrequency thermocoagulation, gamma knife radiosurgery, or . Common examples include anterior cingulotomy, which lesions the dorsal to alleviate obsessive-compulsive symptoms; anterior capsulotomy, targeting the ventral capsule/ for OCD and ; subcaudate tractotomy, severing tracts beneath the ; and limbic leucotomy, combining cingulotomy with subcaudate lesions. These methods, refined since the mid-20th century with MRI guidance, aim for permanent circuit interruption but carry risks of irreversible cognitive or due to non-specific damage. In contrast, modulatory procedures, such as (DBS), employ implantable electrodes to deliver chronic electrical pulses that reversibly alter neural activity without tissue , allowing for parameter adjustments or device deactivation. DBS targets in psychiatric applications often include the ventral capsule/ventral striatum (VC/VS) for OCD, , or subthalamic nucleus, modulating limbic-frontal networks to reduce symptoms in treatment-resistant cases. Introduced for psychiatric use in the following success in , DBS offers ethical advantages through its titratability and potential reversibility, though it requires surgical implantation, periodic battery replacements, and ongoing management of hardware-related complications like infection or lead migration. The primary distinction lies in permanence and adaptability: ablative techniques provide a one-time intervention with sustained effects but no recourse for adverse outcomes, whereas DBS enables dynamic optimization based on patient response, potentially minimizing side effects through programming changes. Meta-analyses of refractory OCD indicate comparable response rates—around 45-60% significant improvement—for both approaches, with benefits emerging over months, though DBS data derive from smaller, often open-label trials compared to ablative procedures' longer historical record. For treatment-resistant depression, ablative options like bilateral anterior capsulotomy show response in up to 50% of cases, while DBS targets yield variable but promising results in pilot studies, favoring modulatory methods in modern practice due to reduced permanence risks despite higher upfront costs. Ablative procedures persist in select centers for patients unsuitable for implantation, underscoring a trade-off between simplicity and flexibility.
AspectAblative ProceduresModulatory Procedures (DBS)
MechanismIrreversible lesioning via , , or Reversible electrical of circuits
ReversibilityNone; effects permanentHigh; adjustable or removable
Common RisksCognitive deficits, hemorrhage (1-5%), personality alteration (3-10%), hardware failure, issues
Efficacy in OCD40-70% response; durable but variable35-65% response; tunable but trial-limited

Clinical Indications and Patient Selection

Targeted Psychiatric Disorders

Psychosurgery targets severe, treatment-resistant psychiatric disorders where conventional therapies, including , , and non-invasive , have failed. The primary indications include obsessive-compulsive disorder (OCD) and (MDD), with procedures such as anterior capsulotomy or cingulotomy aimed at disrupting aberrant neural circuits in the cortico-striato-thalamo-cortical pathways. For OCD, stereotactic lesioning or targets the anterior limb of the or subthalamic nucleus in patients exhibiting profound functional impairment despite at least five adequate trials of selective serotonin reuptake inhibitors and exposure-response prevention therapy. In , psychosurgical interventions focus on mood disorders unresponsive to multiple antidepressant classes, augmentation strategies, and , often involving subcallosal cingulate gyrus lesions to modulate limbic hyperactivity. , particularly unipolar or bipolar depression with melancholic features, represents another targeted condition, though evidence is sparser compared to unipolar MDD. Anxiety disorders, including generalized anxiety and severe chronic cases, have been addressed through procedures like , but usage remains limited due to higher risks of emotional blunting. Emerging applications extend to , , and addiction-related disorders, where refractory tics, body image distortions, or compulsive behaviors persist despite exhaustive non-surgical management. , historically a target, is now rarely indicated owing to inconsistent outcomes and ethical concerns over cognitive deterioration, with modern focus shifting to negative symptoms only in exceptional, cases. Patient selection emphasizes documented refractoriness, typically requiring failure of at least four medication trials and two evidence-based psychotherapies, alongside rigorous multidisciplinary evaluation to confirm and exclude comorbidities like disorders that might mimic primary symptoms.

Criteria for Treatment-Resistant Cases

Patients selected for psychosurgery must demonstrate severe, chronic psychiatric illness that causes significant functional impairment and has proven refractory to exhaustive conventional therapies, including multiple adequate trials of , , and adjunctive interventions such as (ECT) when applicable. Treatment resistance is established through rigorous verification of the primary via standardized assessments, confirmation of adherence to evidence-based regimens at therapeutic doses for sufficient durations, exclusion of confounding comorbidities or substance use disorders, and documentation of persistent symptoms despite optimized non-invasive options. This threshold ensures procedures are reserved for cases where lesser interventions have unequivocally failed, minimizing risks in an irreversible domain. For obsessive-compulsive disorder (OCD), eligibility typically requires a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score exceeding 30, indicating profound severity, alongside failure of at least three selective serotonin reuptake inhibitors (SSRIs) at maximum tolerated doses for 12 weeks each, augmentation strategies (e.g., antipsychotics), and intensive cognitive-behavioral therapy with exposure and response prevention for a minimum of 20 sessions. Candidates must exhibit major functional disability persisting for over five years, with no psychotic features or active suicidality unmanaged by prior means, and undergo multidisciplinary review including psychiatric, neurosurgical, and ethical oversight to affirm capacity for informed consent. In (TRD), criteria emphasize unipolar without psychotic elements, with symptoms enduring at least five years despite trials of four or more antidepressants from different classes (e.g., SSRIs, SNRIs, tricyclics), , and ECT or (TMS). Patients are screened for Hamilton Depression Rating Scale (HAM-D) scores above 20 during evaluation, absence of traits or personality disorders dominating the clinical picture, and overall suitable for surgical candidacy, often capped at ages 18–70 to balance potential benefits against age-related vulnerabilities. Across indications, exclusionary factors include unstable medical conditions, precluding consent, ongoing substance dependence, or primary symptoms attributable to non-psychiatric etiologies such as neurological disorders, underscoring the imperative for precise to avoid misapplication of invasive techniques. Institutional protocols, such as those from specialized centers, mandate prospective case reviews by boards to enforce these standards, reflecting historical lessons from less selective eras where broader application yielded inconsistent outcomes.

Efficacy and Empirical Evidence

Historical Outcome Data

Egas Moniz introduced prefrontal leukotomy in 1935, reporting outcomes from an initial series of 20 patients with chronic psychoses: 7 classified as recovered, 7 as improved, and 6 as unchanged, with better results in depressive cases than in . Across Moniz's experience, roughly 35% of patients achieved complete symptom relief, 35% partial benefit, and 30% no improvement. In the United States, Walter Freeman and James Watts modified the procedure, performing approximately 200 prefrontal lobotomies by 1942 and claiming 63% improvement, 23% unchanged symptoms, and 14% severe deficits or death. A follow-up encompassing 3,000 patients treated from 1936 to 1956 found that, 5–10 years postoperatively, 70% of schizophrenics, 80% of those with affective disorders, and 90% of psychoneurotics functioned outside hospitals, though private patients fared twice as well as cases, and transorbital variants proved safer except in hallucinatory . A review of 10,365 prefrontal lobotomies conducted between 1943 and 1954 confirmed an approximate 70% improvement rate. Longer-term assessments highlighted limitations, including a 1963 evaluation of 116 survivors from a 1948–1952 cohort of 150 mental illness patients, where 67% resided outside hospitals but 91% displayed defects and 12% developed . Operative mortality reached 14% in some series. These figures, derived from largely uncontrolled and subjective evaluations by proponents, often equated improvement with reduced institutional rather than full symptomatic resolution or restored function.

Modern Clinical Trials and Meta-Analyses

Modern psychosurgical interventions, including stereotactic ablative procedures like anterior cingulotomy and capsulotomy, as well as modulatory (DBS), have been evaluated in clinical trials primarily for treatment-resistant obsessive-compulsive disorder (OCD) and, to a lesser extent, (MDD). These studies emphasize targeted lesions or stimulation in circuits involving the , ventral capsule/ventral striatum, and subthalamic nucleus, with outcomes measured via standardized scales such as the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for OCD. Evidence remains derived from small-scale, often open-label trials due to ethical constraints on in refractory cases, with response defined as at least a 35% symptom reduction. A 2015 systematic review of 13 observational studies involving 306 patients with refractory OCD found that anterior capsulotomy achieved response rates of 46-58% at long-term follow-up (mean 5.7 years), while dorsal anterior cingulotomy yielded 27-48% response rates, with both procedures showing sustained Y-BOCS reductions of approximately 40-50% in responders and low rates of serious adverse events (e.g., <5% persistent cognitive deficits). A 2023 of neuroablative interventions, including capsulotomy, reported a mean 50% Y-BOCS reduction at 12 months post-procedure across observational cohorts, comparable to historical ablative data but with improved precision via MRI guidance. Stereotactic radiosurgical capsulotomy, a non-invasive variant using gamma knife, demonstrated similar efficacy in a 2024 prospective of 36 OCD patients, with 58% achieving response at 3 years and no significant difference from radiofrequency methods, though delayed effects (up to 18 months) were noted. For , a 2022 meta-analysis of 8 studies (including 3 randomized controlled trials) on ventral capsule/ventral or subthalamic targets in refractory OCD reported a meta-analytic 47% Y-BOCS reduction (14.3-point drop, p<0.01), with no significant difference between blinded and open-label designs, though heterogeneity was high (I²=70%). A 2025 meta-analysis of versus sham confirmed a 5.1-point Y-BOCS advantage for active (Hedges' g=0.56, 95% CI 2.0-8.1), based on 6 RCTs totaling 89 patients, but highlighted variable response onset (3-12 months) and risks upon adjustments. location analyses from cingulotomy trials, such as a 2021 of 17 patients, linked superior anterior cingulate placements to better outcomes (64% response vs. 25% for inferior), underscoring the importance of imaging-guided targeting. In MDD, DBS evidence is sparser and experimental; a 2018 systematic review and of 5 small trials (n=66) targeting or subcallosal cingulate found moderate symptom reductions (standardized mean difference -0.89) but insufficient powering for superiority claims, with high variability in targets and stimulation protocols. Long-term data from a 2013 cingulotomy series (n=18 OCD patients with comorbid ) showed 50% sustained improvement at 8 years, but comorbid effects were secondary to OCD relief. Overall, meta-analyses indicate moderate efficacy (effect sizes 0.5-1.0) for select cases, but call for larger RCTs to address responses, optimal targets, and generalizability beyond specialized centers.

Risks and Complications

Immediate Postoperative Effects

Immediate postoperative effects of psychosurgery primarily encompass surgical complications common to stereotactic procedures, alongside procedure-specific transient neurological and behavioral alterations. Hemorrhage occurs in approximately 2.5% of ablative cases, such as interstitial thermal therapy used in some psychiatric applications, potentially leading to elevated and requiring urgent intervention. , often perilesional, manifests within hours to days post-procedure and typically resolves with corticosteroids, though severe cases may necessitate prolonged monitoring. Infection rates range from 0% to 3% in modern stereotactic approaches like cingulotomy or capsulotomy, presenting as wound infections, , or abscesses, with risk mitigated by prophylactic antibiotics and stereotactic precision minimizing tissue disruption. Seizures arise in about 4% of patients immediately following ablative for psychiatric disorders, often generalized tonic-clonic and responsive to antiepileptics, attributed to cortical irritation from lesioning. Procedure-targeted disruptions in limbic structures yield transient effects including , reduced initiative, and diminished , observed in up to 10-20% of cingulotomy patients and resolving within weeks to months. , linked to frontal-limbic pathway interruption, affects 2-7% transiently post-cingulotomy or capsulotomy. Confusion or mild may occur due to and surgical stress, with rates akin to general (5-15%), exacerbated in psychiatric patients by baseline cognitive vulnerabilities. Rare major events, such as brainstem , have been reported but occur in <1% with contemporary guidance. Overall, these effects underscore the need for monitoring for 24-48 hours postoperatively to detect and manage complications promptly.

Long-Term Adverse Outcomes

In historical prefrontal lobotomies performed between 1948 and the 1950s, long-term follow-up revealed personality defects in 91% of patients, manifesting as emotional blunting, , and reduced initiative, alongside in 12% of cases. These outcomes often persisted for over a decade, with many patients requiring ongoing institutionalization despite initial symptom relief in selected cases. Cognitive impairments, including diminished intellectual function, were commonly reported, contributing to profound functional limitations such as inability to communicate or in severe instances. Modern ablative procedures like anterior capsulotomy for refractory obsessive-compulsive disorder (OCD) show persistent adverse effects in long-term follow-up averaging 10.9 years, with 43% of patients experiencing significant , apathy, or . Specific complications include (mean 6 kg in the first year, often sustained), , seizures, and sexual leading to social impairment in up to 9% of cases. Only 14% of responders achieved remission without such effects, underscoring the trade-off between symptom reduction and enduring neurobehavioral deficits. Stereotactic cingulotomy yields subtler but notable long-term personality alterations, including increased passivity, reduced emotional tension, and impairments in and such as response initiation. Rare events like (3% in some cohorts) and medication-requiring occur, though overall long-term adverse event rates are lower than in historical psychosurgery. Deep brain stimulation (DBS) for psychiatric indications, such as or OCD, carries risks of sustained psychiatric adverse events including (up to 6.4% non-reversible), anxiety, , and , potentially lasting years and reducing . Cognitive decline affects 3.8-17% over 5-8 years, alongside neurological issues like and speech disturbances. Hardware-related complications necessitate revisions in some patients but are typically reversible, distinguishing DBS from irreversible ablative risks.

Historical Evolution

Origins in the Early 20th Century

The origins of modern psychosurgery trace back to limited experimental efforts in the late 19th century, which laid dormant groundwork into the early 20th. In 1888, Swiss psychiatrist Gottlieb Burckhardt conducted the first systematic psychosurgical interventions on six patients with chronic agitation and psychosis at the Prefargier Asylum, performing bilateral cortical excisions targeting areas such as the temporal and parietal lobes to disrupt aberrant neural pathways. Of these, three patients exhibited partial behavioral improvements, such as reduced hallucinations, but one died from postoperative status epilepticus, and the procedures drew sharp criticism at the 1889 Berlin Medical Congress for high risks, ethical lapses, and insufficient evidence of efficacy, leading Burckhardt to abandon further work. Sporadic human attempts followed in the early 1900s, including isolated cerebral surgeries in 1891 and 1910 for manic-depressive , but these garnered minimal attention amid the era's emphasis on non-invasive asylum care and the absence of robust neuroanatomical rationale. Renewed momentum emerged from animal experimentation: in 1935, Yale physiologist John Fulton and psychologist Carlyle Jacobsen reported at the Second International Neurological Congress in that bilateral prefrontal in chimpanzees attenuated emotional responses to —such as tantrums—while preserving cognitive functions like problem-solving, suggesting the frontal lobes' role in over subcortical drives. This presentation, attended by Portuguese neurologist , provided the causal impetus for translating techniques to humans for intractable psychiatric symptoms, shifting from vague excisions to targeted disconnection of prefrontal-thalamic fibers. Moniz, director of neurology at the University of Lisbon, collaborated with neurosurgeon Almeida Lima to perform the inaugural prefrontal leucotomy on November 12, 1935, on a 63-year-old woman suffering from obsessive ruminations, anxiety, and depressive paranoia unresponsive to other treatments; absolute alcohol was injected into the frontal white matter to lesion connecting fibers. Early refinements replaced injections with a specialized leucotome—a cannula with a retractable wire loop—to achieve more precise sectioning via frontal burr holes. In a 1936 series of 20 patients, primarily with schizophrenia or anxiety disorders, Moniz documented seven as improved or "cured" in terms of reduced agitation, though affective blunting and dependency often ensued, with no immediate deaths but variable long-term validation due to subjective assessments. Moniz coined the term "psychosurgery" in 1936 to describe these interventions, framing them as a rational severance of pathological circuits rather than crude removal, though critics later highlighted the procedure's empirical weaknesses and potential for irreversible personality alterations.

Expansion and Peak Usage (1930s–1950s)

In November 1935, Portuguese neurologist and neurosurgeon Almeida Lima performed the first prefrontal leucotomy in , sectioning fibers between the and using a instrument with a retractable wire loop. This procedure was inspired by observations of behavioral calming in chimpanzees after prefrontal ablation, aiming to alleviate severe symptoms of mental disorders like and amid limited pharmacological options. Initial reports on 20 patients indicated reductions in anxiety, , and agitation in some cases, prompting Moniz to advocate its therapeutic potential. The technique rapidly crossed to the , where neurologist Walter and neurosurgeon James Watts conducted the first American in 1936 on a with , adapting Moniz's method via open to sever frontal connections. By 1942, and Watts had operated on 200 , reporting 63% improvement in manageability, though outcomes varied widely and included deaths. The procedure gained traction due to severe overcrowding in psychiatric institutions—reaching 450,000 across 477 U.S. asylums by 1937—and the absence of effective alternatives for institutionalization-resistant cases. Freeman further innovated in 1946 with the transorbital lobotomy, inserting an (icepick-like tool) through the eye socket to access and sever frontal fibers, enabling quick outpatient procedures under electroshock anesthesia without full surgical teams. This modification democratized access, allowing to perform or supervise over 3,000 lobotomies by 1960, often traveling to state hospitals for mass demonstrations. Moniz's 1949 in Physiology or Medicine for leucotomy reinforced its perceived legitimacy, spurring adoption. Usage peaked in the late to early , with an estimated 60,000 lobotomies conducted in the U.S. and between 1936 and 1956, primarily targeting , , and severe anxiety. In the U.S., procedures disproportionately affected women (nearly 60% of cases per 1951 data), often selected for institutional behaviors deemed disruptive. Freeman's itinerant campaigns, including 228 transorbitals in two weeks across in 1952, exemplified the era's fervor, positioning psychosurgery as a pragmatic solution for deinstitutionalization pressures before antipsychotic drugs like emerged in 1954.

Decline and Regulatory Responses (1960s–1980s)

The advent of effective medications, beginning with chlorpromazine's approval in , precipitated a sharp decline in psychosurgery by offering non-invasive alternatives for controlling symptoms of and other severe disorders, reducing institutional overcrowding without surgical risks. By the early , annual psychosurgical procedures in the United States and had plummeted from thousands in the peak to mere dozens, as accumulating evidence highlighted high rates of , personality ablation, and mortality—outcomes that contrasted poorly with pharmacological efficacy. Ethical controversies intensified in the late 1960s and 1970s, fueled by reports of indiscriminate application on vulnerable populations, including involuntarily committed patients and children, prompting advocates to decry psychosurgery as coercive behavioral control rather than therapeutic intervention. Psychiatrist Peter Breggin's critiques equated modern variants with historical lobotomies, amplifying public distrust and professional self-scrutiny amid broader deinstitutionalization movements. In the , procedures persisted at around 120 annually by 1976 but shifted toward stereotactic techniques with purportedly fewer side effects, though overall usage waned due to these same pharmacological and ethical pressures. Regulatory responses emerged primarily in the United States during the 1970s, driven by federal inquiries into human subjects protections. The National Commission for the Protection of Human Subjects' 1977 report on psychosurgery affirmed its potential utility for treatment-resistant cases under stringent conditions—including , multidisciplinary review, and exclusion of minors or incompetent patients without guardians—but urged institutional review boards to oversee protocols and monitor long-term outcomes. States like enacted laws in 1977 mandating state-level approval and ethical reviews for psychosurgery on public wards, effectively curtailing experimental applications. In the UK, the formalized requirements for a second medical opinion and Mental Health Review Tribunal consent for psychosurgery, codifying safeguards amid the procedure's ongoing rarity by the 1980s. These measures reflected a prioritizing and evidence-based alternatives, further entrenching psychosurgery's marginal status.

Contemporary Revival (1990s–Present)

Following the widespread abandonment of crude psychosurgical techniques in the mid-20th century, a revival occurred in the driven by advancements in stereotactic , which enabled precise targeting of brain circuits implicated in psychiatric disorders using imaging-guided lesioning or stimulation. These methods addressed treatment-resistant conditions such as obsessive-compulsive disorder (OCD), , and anxiety, with procedures limited to patients failing multiple pharmacological and psychotherapeutic interventions. The shift emphasized focal interventions on limbic and prefrontal structures, minimizing compared to historical lobotomies. Key ablative procedures included anterior cingulotomy, targeting the to disrupt obsessive circuits; anterior capsulotomy, lesioning the ventral capsule/ to alleviate intrusive thoughts; and subcaudate tractotomy or limbic leukotomy, which interrupt connections between the and subcortical regions. These stereotactic radiofrequency or ablations were performed under with frame-based or frameless , achieving lesion sizes of 4-10 mm. By the early , such interventions were reported in specialized centers, with subcaudate tractotomy showing sustained symptom reduction in up to 60% of refractory cases over 12 months post-surgery. Non-invasive alternatives emerged via Gamma Knife radiosurgery, delivering focused to create lesions without incision, as in gamma ventral capsulotomy for OCD since the late 1990s. This method, pioneered by Lars Leksell, targeted volumes of 100-200 mm³ with marginal doses of 140-180 Gy, yielding response rates of 45-60% in OCD patients at 3-year follow-up, though with risks of in 5-10%. (DBS), often classified under modern psychosurgical , involved implantable electrodes in targets like the ventral capsule/ventral or , approved under FDA humanitarian device exemption for intractable OCD in 2009. DBS offered reversibility, with acute response rates of 40-60% in randomized trials for severe OCD, improving Yale-Brown Obsessive Compulsive Scale scores by 35% on average. Efficacy data from observational series and meta-analyses indicate 50-70% improvement in core symptoms for ablative procedures in OCD, with capsulotomy demonstrating 53-73% significant response across long-term follow-ups exceeding 5 years. For , DBS targeting the subcallosal cingulate yielded remission in 20-40% of cases after 6-12 months of optimized stimulation, outperforming sham controls in double-blind trials. These outcomes, while promising for end-stage patients, remain supported primarily by non-randomized data, with ongoing multicenter trials addressing variability in target selection and patient heterogeneity. Complications, including transient or hemorrhage (1-5% incidence), underscore the procedures' role as last-resort options under strict ethical oversight.

Global Practices and Variations

Practices in Asia

In , psychosurgery has been practiced since the 1940s, initially by surgeons like Tong-He Zhang in , with expanded use in the 1950s for conditions such as and other refractory psychiatric disorders. By the late , procedures like cingulotomy and capsulotomy were employed widely in state-run facilities, including Ankang hospitals, to manage large numbers of psychiatric patients, often as an ablative intervention when pharmacological options failed. Although the Ministry of Health imposed restrictions in the 2000s limiting civilian hospitals to last-resort ablative psychosurgery for specific diagnoses, neurosurgeons have advocated for easing these bans amid renewed interest in techniques, reflecting a pragmatic response to persistent treatment-resistant cases rather than ethical consensus. In , the first psychosurgical procedure occurred in November 1938, performed by surgeon Mizuho Nakata at Niigata Medical College, targeting prefrontal leucotomy for psychiatric symptoms. Usage peaked mid-century for disorders including and behavioral disturbances but declined sharply by the mid-1970s due to ethical criticisms, advancements in antipsychotic medications like , and shifting medical paradigms, leading to complete cessation of psychosurgical interventions, including , for mental disorders thereafter. India's psychosurgery history began in the early 1940s, with 107 leucotomies performed among 116 invasive brain procedures at Madras General Mental Hospital from 1939 to 1947, primarily for (51.5% of cases), yielding variable outcomes including symptom relief in some but high risks of complications. Contemporary practices are limited and regulated under the Mental Health Care Act of 2017, which restricts psychosurgery to exceptional treatment-resistant cases with and oversight; recent advancements include trials for , with only about 13 such procedures globally by 2023, including pioneering cases in and Gurugram hospitals targeting nuclei like the . These efforts represent cautious integration of stereotactic techniques amid ethical scrutiny, prioritizing over .

Practices in Europe and North America

In and , psychosurgery—now often termed neurosurgery for mental disorders (NMD)—is restricted to specialized centers treating severe, treatment-refractory conditions such as obsessive-compulsive disorder (OCD) and , following exhaustive trials of medications, , and non-invasive . Procedures are ablative, targeting specific neural circuits via stereotactic techniques, including radiofrequency lesioning or gamma knife , with patient selection requiring multidisciplinary evaluation and . Annual procedures number in the low dozens across these regions, reflecting rigorous ethical oversight and regulatory constraints, such as institutional review board (IRB) approval in the United States and certification under the UK's Act. In , cingulotomy, which lesions the to disrupt obsessive thought loops, is the most frequently performed ablative intervention, primarily for intractable OCD. Centers such as University's Psychiatric Neurosurgery Program and the Health offer it as a last-resort option, with historical data from showing 44 patients undergoing the procedure between 1966 and 1991, yielding response rates of 25-45% for OCD symptom reduction in long-term follow-up. Adverse events are low, with serious complications in approximately 5% of cases, though transient effects like occur in 14%. Anterior capsulotomy, targeting the to modulate frontostriatal pathways, is less common but used similarly for OCD and , with meta-analyses reporting 40-60% improvement rates in refractory cases. European practices emphasize procedures like subcaudate tractotomy and limbic leucotomy, the latter combining cingulotomy with subcaudate lesions to address limbic hyperactivity in depression and anxiety disorders. In the , operations declined from 70 annually in 1979 to 15 by 1986, with current volumes even lower due to stringent second-opinion requirements and preference for reversible alternatives like . Anterior capsulotomy persists in select centers for OCD, showing 50-70% response in obsessions and compulsions via gamma knife delivery, though higher transient adverse event rates (up to 56%) limit broader adoption. Overall, these interventions prioritize precision over historical indiscriminate lobotomies, with outcomes tracked via standardized scales like the Yale-Brown Obsessive Compulsive Scale, but long-term personality changes and ethical concerns persist as focal points of debate.

Practices in Other Regions

In , psychosurgery practices emerged in the mid-20th century, mirroring global trends in prefrontal leucotomy adoption. In , the procedure was introduced at the Juquery Psychiatric Hospital in in 1936, coinciding with Egas Moniz's development of the technique, and primarily targeted women for conditions such as and . These interventions continued into the postwar period but declined with the rise of pharmacological alternatives and ethical scrutiny, though specific procedure counts remain underdocumented outside institutional records. Regulatory frameworks in countries like now restrict psychosurgery to rare, refractory cases under multidisciplinary oversight, with limited contemporary application reported. In , psychosurgery arrived in the mid-1940s, beginning in where neurosurgeons adapted leucotomy for institutionalized patients with severe psychiatric disorders. saw leucotomies performed between 1947 and 1970, often on women described in records as achieving a "relaxed, pleasant" state post-procedure, though long-term outcomes included and dependency. By 1992, a survey across and indicated a sharp decline in procedures, attributed to effective psychotropic medications like antipsychotics, with only sporadic stereotactic interventions for obsessive-compulsive disorder persisting under strict ethical guidelines. Current practices emphasize and neuroimaging-guided precision, but annual volumes remain low, typically under a dozen nationwide. African psychosurgery history is sparse in documented modern forms, with prehistoric trephination evident in archaeological finds across the continent, potentially aimed at behavioral modification but predating clinical psychosurgery. Colonial-era leucotomies occurred in regions like British East Africa in the , but systematic data is limited, and contemporary use appears negligible amid resource constraints and preference for non-invasive treatments. In the , no widespread psychosurgical programs are recorded beyond historical neurosurgical advancements, with focus shifting to and for mental disorders. Globally, practices in these regions reflect a transnational diffusion until the , followed by near-cessation outside specialized centers for intractable conditions. In historical psychosurgery procedures, such as prefrontal lobotomies performed en masse from to 1950s, was frequently absent or superficial, with patients or guardians often inadequately informed of irreversible risks like personality alteration and , leading to widespread ethical condemnation by the 1960s. Modern psychosurgery, including (DBS) for refractory obsessive-compulsive disorder (OCD) or , mandates as a legal and ethical prerequisite, requiring patients to demonstrate comprehension of procedure-specific risks—such as infection rates of 1-3% and hemorrhage up to 2%—benefits, alternatives, and voluntariness, assessed via standardized tools like the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR). Capacity to consent hinges on the patient's ability to understand relevant information, appreciate its personal implications, reason through options, and express a choice, particularly challenging in psychiatric disorders where symptoms like delusions or severe anhedonia impair decision-making; for instance, studies of DBS candidates for depression show variable MacCAT-CR scores, with some patients scoring below thresholds for appreciation due to illness severity. Autonomy is further compromised by potential coercion from desperation in treatment-refractory cases or therapeutic optimism bias among clinicians, where patients may overestimate benefits despite evidence of modest efficacy (e.g., OCD response rates of 40-60% in open-label trials). Ethical frameworks emphasize repeated capacity evaluations pre- and post-procedure, given DBS adjustability, but critics argue that incomplete disclosure of long-term unknowns—like device dependency or suicide risk persistence—undermines true voluntarism. Proxy consent arises when patients lack capacity, yet remains contentious for psychosurgery due to its experimental nature and historical abuses; in jurisdictions like , the permits non-consensual DBS for detained patients under clinical necessity, bypassing proxy input, though this conflicts with autonomy principles in international guidelines like those from the . U.S. regulations under 21 CFR 56.109 generally prohibit proxy consent for invasive psychiatric interventions without approval and evidence of minimal risk, with psychosurgery explicitly restricted in many states to prevent surrogate overreach. Debates center on whether proxies—typically family—can authentically represent patient values amid conflicts of interest or , with empirical data indicating proxies often prioritize symptom relief over quality-of-life concerns, potentially justifying substituted judgment only for reversible procedures rather than ablative ones.

Professional and Societal Debates

Professional neurosurgeons and psychiatrists continue to debate the role of psychosurgery in treating severe, treatment-resistant psychiatric disorders such as obsessive-compulsive disorder (OCD), where procedures like anterior cingulotomy or (DBS) target specific neural circuits. Proponents argue that these interventions offer meaningful symptom relief in 32-45% of patients unresponsive to medications and behavioral therapies, as evidenced by long-term follow-up studies of cingulotomy cases, justifying their use as a last-resort option when is profoundly impaired. Critics within the field, however, highlight insufficient data due to ethical barriers against sham surgeries, alongside risks of persistent cognitive deficits, , or seizures in up to 10% of cases, questioning whether observed benefits stem from precise targeting or effects. Central to professional ethical debates are issues of patient selection, , and , particularly for individuals with impaired decision-making capacity from their disorders. Guidelines emphasize multidisciplinary evaluation, including independent ethical review boards, to mitigate historical risks of or inadequate assessment, yet surveys of clinicians reveal ongoing tensions over balancing refractory criteria against potential personality alterations that could undermine . For instance, in for psychiatric indications, debates focus on whether device adjustments post-implantation respect evolving patient preferences or introduce undue clinician control, with some ethicists advocating adaptive models to address these dynamics. Opponents contend that the irreversible nature of ablative procedures like capsulotomy amplifies these concerns, advocating stricter evidence thresholds before expansion beyond OCD. Societally, psychosurgery evokes persistent rooted in mid-20th-century lobotomies, which caused widespread personality blunting and fueled public backlash leading to regulatory bans in many countries by the . Contemporary revival through refined techniques has prompted cautious optimism in some quarters, with shifting medical opinions viewing it as viable for refractory cases, yet critics decry over-optimistic media portrayals that echo past hype without addressing neural specificity uncertainties. Public reluctance persists, often framing interventions as threats to or tools for behavioral control, amplified by historical associations with eugenics-era abuses, though advocacy from groups highlights desperation in untreatable . This tension underscores broader societal debates on neuromodulation's boundaries, with calls for transparent reporting to rebuild trust amid fears of commercial or political misuse.

Contemporary Developments and Future Directions

Integration with Neuromodulation Technologies

In contemporary psychiatric neurosurgery, integration with neuromodulation technologies has transformed psychosurgery from predominantly ablative techniques to reversible, stimulatory interventions that target similar neural circuits while mitigating risks of permanent tissue damage. (DBS), the foremost such technology, entails surgically implanting electrodes into subcortical structures—such as the ventral capsule/ventral for obsessive-compulsive (OCD) or the subcallosal cingulate for —to deliver adjustable electrical impulses that modulate aberrant activity in limbic and frontostriatal networks historically lesioned in procedures like capsulotomy or cingulotomy. This evolution prioritizes DBS over ablation due to its capacity for titration, deactivation, or hardware removal, enabling empirical assessment of therapeutic effects without irreversible commitment. Clinical outcomes underscore this integration's viability for treatment-resistant cases. In OCD, prospective multicenter trials report DBS yielding a mean 40% reduction in Yale-Brown Obsessive Compulsive Scale scores, with approximately two-thirds of patients achieving clinically significant improvement, often alongside alleviation of comorbid . For , DBS has demonstrated response rates of 45-60% in open-label studies, with sustained benefits observed up to five years post-implantation in responders, though sham-controlled trials remain limited by ethical constraints on withholding intervention from severely ill patients. These results parallel historical ablative successes but with lower complication rates, as DBS avoids lesion-related cognitive deficits reported in 10-20% of early psychosurgical cases. Beyond , (VNS) and responsive neurostimulation integrate psychosurgical principles by indirectly influencing psychiatric symptomatology through afferent pathways to mood-regulating brain regions, approved for but investigated off-label for with modest effect sizes (e.g., 20-30% response augmentation when adjunctive to antidepressants). Emerging closed-loop systems, which adapt stimulation parameters in real-time based on , further refine this integration by enhancing precision akin to stereotactic targeting in traditional psychosurgery, potentially improving efficacy in heterogeneous disorders like bipolar mania. Regulatory approvals, such as the FDA's 2009 humanitarian device exemption for in OCD, reflect growing acceptance, though long-term data emphasize the need for rigorous selection via multidisciplinary to optimize outcomes and address risks like (2-5% incidence) or hardware .

Ongoing Research and Policy Shifts

Recent clinical trials have demonstrated efficacy of stereotactic ablative procedures like bilateral anterior capsulotomy for treatment-resistant obsessive-compulsive disorder (OCD), with one systematic review reporting a 67% responder rate (defined as ≥35% reduction in Yale-Brown Obsessive-Compulsive Scale scores) and 33% achieving ≥50% reduction among participants. Similarly, observational studies on capsulotomy for OCD at 12-month follow-up indicate average symptom reductions, supporting its role in severe, refractory cases where pharmacological and behavioral therapies fail. Cingulotomy trials for intractable OCD have shown sustained benefits without significant adverse cognitive effects, as evidenced by long-term follow-up data from specialized centers. Emerging applications include ventral-targeted anterior capsulotomy for comorbid treatment-resistant depression and OCD, with 2024 studies reporting improved outcomes in symptom severity and functionality. Investigations into stereotactic variants, such as gamma knife capsulotomy, continue for psychiatric indications, with moderate-to-severe OCD patients exhibiting higher response rates (80% in small cohorts) compared to extreme cases. Research emphasizes patient selection criteria like chronicity, treatment resistance, and biomarkers to predict outcomes, as analyzed in systematic reviews of ablative and neuromodulatory approaches. These efforts reflect a shift toward techniques, including connectomics-guided targeting, to minimize risks associated with historical psychosurgery. Policy landscapes have evolved to facilitate ethical research resumption, with U.S. and European frameworks now prioritizing rigorous , multidisciplinary oversight, and prospective registries over outright bans from the mid-20th century. guidelines, informed by past abuses, mandate demonstration of treatment refractoriness and assessment, enabling limited approvals in centers like those in and where procedures persist for OCD and . Recent analyses highlight opportunities for expanded trials amid advances in safety, though threats include public stigma and variable regulatory stringency across regions. This cautious liberalization aligns with evidence of net benefits in select cohorts, prompting calls for standardized global protocols to balance innovation and .

References

  1. [1]
    Psychosurgery: past, present, and future - PubMed
    Psychosurgery, the neurosurgical treatment of psychiatric disease, has a history dating back to antiquity, and involves all of the clinical neurosciences.
  2. [2]
    A brief history of psychosurgery: Part 1 – From trephination to lobotomy
    Apr 5, 2013 · Psychosurgery was developed early in human prehistory (trephination) as a need perhaps to alter aberrant behavior and treat mental illness.
  3. [3]
    Egas Moniz – Facts - NobelPrize.org
    Egas Moniz introduced lobotomy, a surgical operation involving an incision into the prefrontal lobe to mitigate severe symptoms of serious mental illnesses.
  4. [4]
    Evolution in the Treatment of Psychiatric Disorders - PubMed Central
    Feb 15, 2019 · The controversy surrounding psychosurgery was instrumental in developing modern standards for research and ethics, with the passing of the ...
  5. [5]
    Psychosurgery for schizophrenia: history and perspectives - PMC
    The value of psychosurgery remains controversial. There are no data available to support the use of stereotactic procedures for schizophrenia. Well designed ...
  6. [6]
    Surgical treatment of obsessive compulsive disorders: Current status
    Surgery for intractable neuropsychiatric illness has generated considerable controversy for a variety of scientific, social, and philosophical reasons.
  7. [7]
    The Evolution of Modern Ablative Surgery for the Treatment of ...
    Apr 5, 2022 · Keywords: cingulotomy, subcaudate tractotomy, psychosurgery, OCD, depression, limbic leucotomy. Citation: Mustroph ML, Cosgrove GR and ...
  8. [8]
    The Legacy of Egas Moniz: Triumphs and Controversies in Medical ...
    Oct 21, 2024 · Although he was nominated twice for the Nobel Prize for his cerebral imaging research, Moniz ultimately won the prize for his work in ...
  9. [9]
    Psychosurgery: Review of Latest Concepts and Applications
    Oct 26, 2012 · Psychosurgery existed long before the advent of the frontal lobotomy. There is an archeological evidence of human skull.
  10. [10]
    António Egas Moniz (1874–1955): Lobotomy pioneer and Nobel ...
    The instrument, named a leucotome, allowed the wire to travel through the posterior aspect of the frontal lobe, cutting through the white matter fibres of the ...Missing: mechanism | Show results with:mechanism
  11. [11]
    Reviews Psychosurgery: past, present, and future - ScienceDirect.com
    The origins of psychosurgery will be traced from antiquity, with a more recent historical perspective developed from the mid-19th century and the genesis of ...
  12. [12]
    History of Psychosurgery: A Psychiatrist's Perspective - ScienceDirect
    We begin by discussing early approaches to psychosurgery, focusing on the widespread use of lobotomy and the subsequent backlash from the public and ...Missing: definition | Show results with:definition
  13. [13]
    Psychosurgery in the History of Stereotactic Functional Neurosurgery
    Jun 29, 2020 · The paper invites to reappraise the role of psychosurgery for and within the development of functional stereotactic neurosurgery.Missing: principles | Show results with:principles
  14. [14]
    The Evolution of Modern Ablative Surgery for the Treatment of ...
    Apr 6, 2022 · In this review, we describe the evolution of modern ablative surgery for intractable psychiatric disease, from the original image-guided cingulotomy procedure.
  15. [15]
    The Co-evolution of Neuroimaging and Psychiatric Neurosurgery
    In summary, a neurobiological mechanism for both cingulotomy and capsulotomy is supported by modern fMRI and structural MRI data. These neuroablative ...
  16. [16]
    The early argument for prefrontal leucotomy - Journal of Neurosurgery
    Both occurrences are said to have influenced Portuguese neurologist Egas Moniz. (1874–1955) to commence performing leucotomies on patients beginning in late ...
  17. [17]
    Controversial Psychosurgery Resulted in a Nobel Prize
    Oct 29, 1998 · The treatment became rather popular in many countries all over the world and Moniz received the Nobel Prize in 1949.
  18. [18]
    Psychosurgery, ethics, and media: a history of Walter Freeman and ...
    Although psychosurgery now includes more humane and less invasive means of treating mental disorders, Freeman's complicated legacy provokes ethical and ...Missing: principles | Show results with:principles
  19. [19]
    Lobotomy: The brain op described as 'easier than curing a toothache'
    Jan 29, 2021 · In 1946 he devised the "transorbital lobotomy" in which steel instruments resembling ice picks were hammered into the brain through the fragile ...
  20. [20]
    History of psychosurgery: a psychiatrist's perspective - PubMed
    We begin by discussing early approaches to psychosurgery, focusing on the widespread use of lobotomy and the subsequent backlash from the public and ...
  21. [21]
    Ablative Limbic System Surgery: Review and Future Directions - PMC
    Nov 19, 2019 · The major ablative limbic system procedures currently used are anterior capsulotomy, dorsal anterior cingulotomy, subcaudate tractotomy, and ...
  22. [22]
    Neuromodulation Surgery for Psychiatric Disorders - StatPearls - NCBI
    ... psychosurgical procedures still used today in some cases. The concept of DBS in ... Despite the initial lousy reputation of ablative psychosurgery, modern ...
  23. [23]
    Deep Brain Stimulation for Psychiatric Disorders - PMC
    In this review, we describe the development and justification for testing DBS for various psychiatric disorders, carefully consider the available clinical data ...Missing: psychosurgery | Show results with:psychosurgery
  24. [24]
    Ablative neurosurgery and deep brain stimulation for obsessive ...
    The commonly performed ablative surgeries include GVC and anterior cingulotomy. The most common targets for DBS in OCD include the VC/VS and subthalamic ...
  25. [25]
    Deep brain stimulation for psychiatric disorders: where we are now in
    This review presents a brief history of psychosurgery and summarizes the development of DBS ... As in DBS for movement disorders, the neuro-modulatory ...
  26. [26]
    Therapeutic stimulation versus ablation - ScienceDirect.com
    This chapter discusses the pros and cons of ablation versus stimulation and investigates the reasons why DBS has overshadowed proven efficient ablative ...
  27. [27]
    Deep brain stimulation versus ablative surgery for treatment ...
    Conclusion This meta‐analysis shows equal efficacy of ABL and DBS in the treatment of refractory OCD. For now, the choice of intervention should, therefore, ...
  28. [28]
    Ablation Surgeries for Treatment-Resistant Depression - PubMed
    Aug 16, 2022 · As a standalone neurosurgical procedure, we found that BAC appears to be the most effective and safest of all the ablative targets for TRD.
  29. [29]
    Severe Refractory Obsessive Compulsive Disorder and Depression
    Mar 4, 2024 · The evidence base for neurosurgery in TRD is less robust than that for OCD. Stereotactic ACAPS and ACING are the most common ablative procedures ...
  30. [30]
    Stereotactic Ablation and Deep Brain Stimulation for OCD - Nature
    Sep 16, 2009 · Psychiatric neurosurgery has consistently yielded substantial improvement in symptoms and functioning in ∼35–70% of cases, with morbidity and ...
  31. [31]
    Past and Present Role of Neurosurgical Interventions in the ...
    Feb 14, 2025 · Deep brain stimulation (DBS) has been used in the treatment of a multitude of psychiatric disorders such as treatment-resistant depression, ...Missing: modulatory | Show results with:modulatory
  32. [32]
    Modern neurosurgical techniques for psychiatric disorders
    The most studied psychiatric illnesses amenable to psychosurgical interventions are MDD, OCD, Tourette syndrome (TS), anorexia nervosa, schizophrenia, and ...
  33. [33]
    Lesion procedures in psychiatric neurosurgery - PubMed
    This review provides a brief history of psychiatric surgery and addresses the most recent literature on lesion surgery for the treatment of anxiety and mood ...
  34. [34]
    Neurosurgery for psychiatric disorders in the modern era - Sciety
    May 20, 2025 · This systematic review aims to comprehensively evaluate the current psychosurgery landscape from 2000 onwards, comparing patient demographics, functional ...Missing: targeted indications
  35. [35]
    Long-Term Outcome of Neurosurgery for the Treatment of Resistant ...
    Nov 1, 2005 · Our study demonstrated that a proportion of patients with resistant depression respond to orbitomedial frontal surgical lesions with significant ...
  36. [36]
    Treatment resistance in psychiatry: state of the art and new directions
    Establishing treatment resistance requires concurrent confirmation of the following: 1) that the correct psychiatric diagnosis has been made; 2) that a patient ...
  37. [37]
    Psychosurgery - an overview | ScienceDirect Topics
    Psychosurgery refers to an ensemble of more or less invasive techniques designed to reduce the burden caused by psychiatric diseases.
  38. [38]
    Psychiatric Neurosurgery Program - Butler Hospital
    Who is eligible for surgery? · Are between the ages of 18 and 70 years old. · Have intractable OCD resulting in major functional impairment, and are in good ...<|separator|>
  39. [39]
    Robotic Guided Bilateral Anterior Cingulate Radiofrequency... - LWW
    OCD specific CBT (exposure and response prevention for at least 20 sessions). Approval from the mental health review board should be sought before proceeding ...
  40. [40]
    Psychiatric Neurosurgery Program - University of Utah Health
    You have suffered from treatment-resistant OCD or treatment-resistant depression for more than five years. · You must have undergone all standard treatments ( ...
  41. [41]
    Cingulotomy for intractable obsessive-compulsive disorder ...
    Cingulotomy remains a last resort treatment for severely incapacitated patients who have not responded to all other state-of-the-art pharmacological and ...
  42. [42]
    Long-Term Success with Deep Brain Stimulation for Treatment ...
    Apr 7, 2025 · Participants were carefully screened—only those with severe, unipolar depression lasting over five years and resistant to medications, therapy, ...
  43. [43]
    Deep Brain Stimulation (DBS) Therapy for Treatment Resistant ...
    Inclusion Criteria: Major Depression Disorder (MDD) diagnosed by Structured Clinical Interview for DSM-IV (SCID I/DSM-IV), judged to be of ...
  44. [44]
    Deep Brain Stimulation in Treatment-Resistant Depression - Frontiers
    Mar 31, 2021 · Deep brain stimulation (DBS) has shown promising outcomes as new therapeutic opportunities for patients with treatment-resistant depression (TRD)Abstract · Introduction · Materials and Methods · Discussion
  45. [45]
    Treatment ResistAnt Depression Subcallosal CingulatE Network ...
    Inclusion Criteria: 1. The patient must be diagnosed with non-psychotic unipolar Major Depressive Disorder. 2. The patient must be in a major depressive ...
  46. [46]
    [PDF] Stereotactic Ablation and Deep Brain Stimulation for OCD
    Sep 16, 2009 · Treatment of psychiatric illness by stereotactic cingulotomy. Biol ... Review of long-term results of stereotactic psychosurgery.<|separator|>
  47. [47]
    PREFRONTAL LOBOTOMY IN CHRONIC SCHIZOPHRENIA | JAMA
    He published results in 20 cases, of which 7 were classed as recovered, 7 as improved and 6 as not benefited. The best results appeared in cases of depression, ...
  48. [48]
    FRONTAL LOBOTOMY 1936-1956 A FOLLOW-UP STUDY OF 3000 ...
    Apr 1, 2006 · Follow-up studies reveal that following prefrontal lobotomy some 70% of schizophrenics, 80% of affectives, and 90% of psychoneurotics are ...
  49. [49]
    The Lobotomy Patient—A Decade Later: A Follow-up Study of ... - NIH
    One hundred and fifty patients with chronic mental illness were treated with prefrontal lobotomy between 1948 and 1952 as part of a research study.
  50. [50]
    Lessons to be learnt from the history of lobotomy
    Dec 12, 2022 · They concluded that prefrontal leucotomy was a simple, failsafe operation that was useful in the treatment of some mental disorders (1, 2). They ...Missing: rationale | Show results with:rationale
  51. [51]
    Neuroablative Intervention for Refractory Obsessive-Compulsive ...
    Nov 21, 2023 · Beginning of psychosurgery. Psychosurgery was introduced in the early 1900s before the emergence of psychopharmacology. In 1936, Moniz published ...
  52. [52]
    Dorsal anterior cingulotomy and anterior capsulotomy for ... - PubMed
    Aug 7, 2015 · This systematic review of the literature supports the efficacy of both dorsal anterior cingulotomy and anterior capsulotomy in this highly treatment-refractory ...
  53. [53]
    Benefits of stereotactic radiosurgical anterior capsulotomy for ...
    Mar 29, 2024 · Stereotactic radiosurgical AC is an effective technique for treating OCD. Its efficacy is similar to that of AC performed via other lesioning techniques.
  54. [54]
    Efficacy of deep brain stimulation for treatment-resistant obsessive ...
    A random-effects model indicated a meta-analytical average 14.3 point or 47% reduction (p<0.01) in Y-BOCS scores without significant difference between RCTs and ...Methods · Results · DiscussionMissing: psychosurgery | Show results with:psychosurgery
  55. [55]
    Deep brain stimulation for obsessive-compulsive-disorder - Nature
    Jun 27, 2025 · Meta-analysis showed a decrease of 5.1 YBOCS points in favor of DBS compared to sham (95% confidence interval, CI, 2.0–8.1, 0.56 Hedges' g). OR ...
  56. [56]
    Lesion location and outcome following cingulotomy for obsessive ...
    Jul 9, 2021 · Our study describes a relationship between lesion placement and clinical outcome following cingulotomy for OCD. More superiorly placed lesions ...
  57. [57]
    A systematic review and meta-analysis of deep brain stimulation for ...
    Conclusions: DBS may show promise for treatment-resistant depression but remains an experimental treatment until further data are available. Keywords: brain ...
  58. [58]
    Long-Term Efficacy of Stereotactic Bilateral Anterior Cingulotomy ...
    May 7, 2013 · The patients ultimately approved for surgery met DSM-IV criteria [4] for OCD. They were determined to be treatment-resistant if they had not ...<|separator|>
  59. [59]
    Ablative brain surgery: an overview - Taylor & Francis Online
    The main complications of LITT in brain tumor cases were neurological deficits (13% transient and 3% permanent), seizures, hemorrhage (2.5%), edema, infection ...
  60. [60]
    Anterior cingulotomy for intractable pain - ScienceDirect.com
    Patients recover well enough for discharge from the procedure after approximately 4 days, but some report recovery in as little as 48 h postoperatively.
  61. [61]
    Ablative neurosurgery and deep brain stimulation for... - LWW
    The risk for immediate postoperative seizures is around 4%; Device related: Breakage of lead or extension wire (around 2%) or device-related discomfort may ...Presurgical Workup · Anterior Cingulotomy · Outcomes<|control11|><|separator|>
  62. [62]
    Cingulotomy for Intractable Pain: A Systematic Review of an ... - NIH
    Mar 22, 2024 · Although severe adverse events are uncommon, certain transient effects have been observed in the immediate postoperative phase, including ...
  63. [63]
    Prospective Long-Term Follow-Up of 44 Patients Who Received ...
    Cingulotomy remains a viable treatment option for patients with severe treatment-refractory OCD. Obsessive-compulsive disorder (OCD) has a lifetime prevalence ...
  64. [64]
    Stereotactic cingulotomy and capsulotomy for obsessive-compulsive ...
    The main indications for performing stereotactic cingulotomy are unipolar and bipolar depressions, obsessive-compulsive disorders and non-curable pain syndromes ...
  65. [65]
    Selective Anterior Cingulotomy: A Psychosurgical Evaluation in
    A brainstem thrombosis in the immediate postoperative period was a major complication. Eight patients in the “well” or “greatly improved” group were followed ...
  66. [66]
    The Long-term Effects of Prefrontal Leukotomy | JAMA Neurology
    Dynes JB: Lobotomy 20 years later . Va Med 1968;95:306. 8. Hamlin RM: Intellectual function 14 years after frontal lobe surgery . Cortex 1970;6 ...
  67. [67]
    Capsulotomy for Obsessive-Compulsive Disorder: Long-term Follow ...
    Aug 4, 2008 · Few studies have systematically assessed adverse effects after capsulotomy ... Bejerot S Psychosurgery for obsessive-compulsive disorder: concerns ...
  68. [68]
    Emotional and personality changes following cingulotomy - PubMed
    Cingulotomy patients experienced reductions in POMS-Tension, POMS-Anger, and MMPI Scale 7 (Psychasthenia) compared with baseline and the controls. POMS-Tension ...
  69. [69]
    Impairments of attention after cingulotomy : Neurology - Ovid
    After cingulotomy, many families spontaneously reported subtle changes in patient personality; most common were reports of increased passivity, a reduction in ...Article Abstract · Conclusion · Figure
  70. [70]
    Adverse events in deep brain stimulation: A retrospective long-term ...
    Jul 5, 2017 · Other psychiatric AEs included sleep disturbances and nightmares, fatigue, somatoform disorder, convulsive sobbing, personality disorder trait, ...
  71. [71]
    Exploring adverse effects of deep brain stimulation - PubMed
    Oct 8, 2024 · Psychiatric side effects such as depression, anxiety, and psychosis further complicate treatment outcomes. These findings underscore the ...
  72. [72]
    Long-term outcome of subthalamic nucleus deep brain stimulation ...
    In our series, severe cognitive decline was observed in 17.1% and 16.7% of the patients at 5 and 8 years respectively. Conclusions Our data confirm that STN-DBS ...Methods · Motor Outcomes · Correlations Of Clinical...
  73. [73]
    Modern psychosurgery before Egas Moniz: a tribute to Gottlieb ...
    Apr 3, 2008 · The transition to the modern era of psychosurgery starts with the series of topectomy operations performed by Gottlieb Burckhardt, the Swiss ...Missing: Gotthard | Show results with:Gotthard
  74. [74]
    The Controversial History of the Lobotomy - Psych Central
    May 6, 2022 · Lobotomies were widely used from the late 1930s through the early 1950s. ... history of psychosurgery: Part 1 - From trephination to lobotomy.<|separator|>
  75. [75]
    A Lobotomy Timeline - NPR
    Nov 16, 2005 · Nov. 12, 1935: Neurologist Egas Moniz performs first brain surgery to treat mental illness in Portugal. He calls the procedure, "leucotomy.".<|separator|>
  76. [76]
    Psychosurgery - Wikipedia
    For the Tourniquet album, see Psycho Surgery. Psychosurgery, also called neurosurgery for mental disorder (NMD), is the neurosurgical treatment of mental ...Missing: conceptual | Show results with:conceptual
  77. [77]
    Psychosurgery (1974–2014). Withdrawals and revivals. New ...
    Between 1950 and 1960, psychosurgery practices declined for good. · Several authors point to a European resistance to the practice of psychosurgery until the ...
  78. [78]
    Psychosurgery-Old and New - Psychiatric Times
    Despite its wretched history, psychosurgery is back with a new name-neurosurgery for mental disorders-and with renewed confidence in its benefits.<|separator|>
  79. [79]
    The Surgical Elimination of Violence? Conflicting Attitudes towards ...
    In the 1970s a public controversy erupted over the proposed use of brain operations to curtail violent behavior. Civil libertarians, civil rights and ...Missing: regulations | Show results with:regulations
  80. [80]
    History of psychosurgery - Wikipedia
    Psychosurgery, also called neurosurgery for mental disorder or functional neurosurgery, is surgery in which brain tissue is destroyed with the aim of ...
  81. [81]
    History of psychosurgery in the United Kingdom - Wikipedia
    The first systematic attempt at psychosurgery is commonly attributed to the Swiss psychiatrist Gottlieb Burckhardt who operated on six patients in 1888. In 1889 ...Missing: Gotthard | Show results with:Gotthard<|separator|>
  82. [82]
    [PDF] PSYCHOSURGERY: REPORT AND RECOMMENDATIONS
    Mar 14, 1977 · The effectiveness of psychosurgery in alleviating symptoms or in restoring normal function- ing was assessed in both studies by standard ...
  83. [83]
    [PDF] An Examination of the National Commission Report on Psychosurgery
    Jun 11, 1976 · in March 1977, concluded that psychosurgery is appropriate for both voluntarily and involuntarily committed patients under certain circumstances ...
  84. [84]
    Legal Regulation of Psychosurgery: A Fifty-State Survey
    This article canvasses, organizes, and analyzes the existing body of United States statutes and regulations mentioning psychosurgery.
  85. [85]
    International Legal Approaches to Neurosurgery for Psychiatric ...
    Jan 13, 2021 · These techniques count as psychosurgery under the law only where they are used for specified purposes: altering behavior or treating psychiatric ...<|separator|>
  86. [86]
    [PDF] Psychosurgery: The Law's Response
    Throughout the 1950s and 1960s, psychosurgery was ignored by the legal community. During this time, however, there existed and continued to de- velop a general ...
  87. [87]
    Neurosurgery for psychiatric disorders: reviewing the past and ...
    Surgical techniques targeting behavioral disorders date back thousands of years. In this review, the authors discuss the history of neurosurgery for ...
  88. [88]
    Modern Gamma Knife radiosurgery for management of psychiatric ...
    Modern Gamma Knife radiosurgery for management of psychiatric disorders ... Psychosurgery* / methods; Quality of Life; Radiosurgery* / adverse effects ...
  89. [89]
    Gamma knife radiosurgery in psychiatry: a review
    May 6, 2024 · Main aim of such psychosurgery is improvement of the patient's quality of life, reducing compulsions, obsessions, anxiety and depression by ...
  90. [90]
    Deep Brain Stimulation for Highly Treatment-Resistant OCD
    Another important development for treatment-resistant OCD is deep brain stimulation (DBS). DBS has been used since the mid-1980s to treat movement disorders ...
  91. [91]
    A randomised, double-blind, sham-controlled trial of deep brain ...
    Mar 29, 2021 · Deep brain stimulation (DBS) is a promising treatment for severe, treatment-resistant obsessive-compulsive disorder (OCD).
  92. [92]
    Use of deep brain stimulation in treatment-resistant depression
    Chronic stimulation of the ventral internal capsule/ventral striatum has been shown to improve function and mood in patients with severe obsessive-compulsive ...
  93. [93]
    Deep brain stimulation for obsessive-compulsive disorder - NIH
    CONCLUSION. The present review confirms that DBS is a promising therapy for patients with severe resistant OCD, providing both ST and LT evidence of efficacy.
  94. [94]
    A comparative history of psychosurgery - ScienceDirect.com
    The term “psychosurgery” reflecting neurosurgical treatment of mental disorders, was coined by a Portuguese neurologist Egas Moniz (1874–1955), who, ...
  95. [95]
    [PDF] The Ankang: China's Special Psychiatric Hospitals
    Mar 25, 2003 · Articles in the Chinese medical literature over the past decade have emphasised how effective the psychosurgery programme has been in reducing ...<|separator|>
  96. [96]
    Psychosurgery. Chinese neurosurgeons quietly push for easing of ...
    Psychosurgery. Chinese neurosurgeons quietly push for easing of brain operation ban.
  97. [97]
    Chinese Neurosurgeons Quietly Push for Easing of Brain Operation ...
    Riding that tide of interest, hospitals in China began to practice psychosurgery widely to cope with a legion of psychiatric patients. According to the ...
  98. [98]
    A brief note on the history of psychosurgery in Japan in
    In Japan, there has been no neurosurgical treatment for psychiatric disorders since the 1970s. Even deep brain stimulation (DBS) has not been studied or used ...Missing: Asia | Show results with:Asia
  99. [99]
    A brief note on the history of psychosurgery in Japan - PubMed
    In Japan, there has been no neurosurgical treatment for psychiatric disorders since the 1970s. Even deep brain stimulation (DBS) has not been studied or used ...Missing: practices | Show results with:practices
  100. [100]
    A brief note on the history of psychosurgery in Japan - ResearchGate
    In Japan, there has been no neurosurgical treatment for psychiatric disorders since the 1970s. Even deep brain stimulation (DBS) has not been studied or used ...
  101. [101]
    The Initial Epoch of Psychosurgery in India: A Retrospective Data ...
    Aug 8, 2022 · Among the 2584 admissions from. 1939 to 1947, 116 individuals underwent invasive brain procedures. Nine patients with a diagnosis of epilepsy ...
  102. [102]
    Psychosurgery in Indian Scenario: Time to Think with Phronesis
    Apr 30, 2024 · However, the use of neurosurgical procedures in psychiatry carries the baggage of memories of psychosurgery. Different neurosurgical techniques ...
  103. [103]
    Rare psychosurgery in Gurugram: Can deep brain stimulation (DBS ...
    Jun 29, 2023 · Psychosurgery is a new field and could help those suffering from treatment-resistant schizophrenia, a complex psychiatric disorder that affects ...
  104. [104]
    [PDF] Deep Brain Stimulation: The Future of Mental Illness Treatment in India
    The mental health legislation of India permits psychosurgery under certain restrictions communicated under the section 96 of the Mental. Healthcare Act, 2017.<|control11|><|separator|>
  105. [105]
    International Legal Approaches to Neurosurgery for Psychiatric ...
    Jan 12, 2021 · This article reviews NPD-specific laws drawn from North and South America, Asia and Europe, in order to identify the typical form and contents of these laws.
  106. [106]
    Dorsal anterior cingulotomy and anterior capsulotomy for severe ...
    Aug 7, 2015 · The rate of serious or permanent AEs was 5.2% across cingulotomy studies and 21.4% across capsulotomy studies.
  107. [107]
    Psychiatric Neurosurgery Program
    Brown University is a world-leader in the application of surgical techniques for severe, intractable psychiatric disorders.
  108. [108]
    Psychosurgery in Britain now - PubMed
    Between 1979 and 1986 the number of psychosurgical operations carried out in Britain fell from 70 to 15 procedures annually. There are a number of possible ...
  109. [109]
    Results of Gamma Knife anterior capsulotomy for refractory ...
    Sep 14, 2018 · It reduces both obsessions and compulsions, improves quality of life, and diminishes depression and anxiety.Missing: Europe | Show results with:Europe
  110. [110]
    Anterior capsulotomy for obsessive-compulsive disorder: a review of ...
    Oct 11, 2019 · However, currently there is cautious optimism that psychosurgery or neurosurgery for mental disorders (NMD) has learned from its past. The field ...Missing: immediate | Show results with:immediate
  111. [111]
    In a psychiatric hospital in São Paulo, women were the preferred ...
    Mar 21, 2022 · Psychosurgery arrived at Juquery in 1936, the same year that Egas Moniz developed prefrontal leucotomy, the origin of other psychosurgical ...
  112. [112]
    The advent of psychosurgery in Australia-with particular attention to ...
    This paper describes the arrival of psychosurgery in Sydney in the mid-1940s, and less comprehensively, its arrival in other Australian cities.
  113. [113]
    women undergoing leucotomy in Western Australia, 1947-1970
    Apr 2, 2018 · Psychosurgery – especially leucotomy (called lobotomy in the US) – is probably one of the most misunderstood elements in twentieth century ...Missing: Oceania | Show results with:Oceania
  114. [114]
    The present status of psychosurgery in Australia and New Zealand
    Jul 6, 1992 · Objectives: To assess the extent and nature of psychosurgery currently being performed in Australia and New Zealand, and the present status ...Missing: Oceania | Show results with:Oceania
  115. [115]
    The present status of psychosurgery in Australia and New Zealand
    Jul 1, 1992 · Objectives To assess the extent and nature of psychosurgery currently being performed in Australia and New Zealand, and the present status ...Missing: Oceania | Show results with:Oceania
  116. [116]
    The history of trephination in Africa with a discussion of its current ...
    African trephination was known in Herodotus' time, has a rich history, and is currently practiced widely throughout Africa for specific reasons.
  117. [117]
    Notes on the Recent History of Neuroscience in Africa - Frontiers
    As in many African countries that were colonized by Britain, the development of modern neurosurgical procedures in Kenya occurred in the late 1940s, as a result ...
  118. [118]
    A transnational perspective on psychosurgery: beyond Portugal and ...
    From its inception in 1935 until its decline in the mid-1960s, psychosurgery was performed on almost all continents. Rather than being a phenomenon isolated to ...Missing: Europe North Asia
  119. [119]
    [PDF] Psychosurgery and Informed Consent
    1950, at 44. 4. See generally BROWN, supra note 2. The first modern psychosurgical operation was called a "lobotomy." In neuroanatomical terminology the ...
  120. [120]
    Ethics in psychosurgery - ScienceDirect.com
    Psychosurgery is defined by a listing of neurosurgical procedures that have direct effects on thought, emotion, or behavior (Elgar, 1975). According to Walter ...Missing: neural | Show results with:neural<|control11|><|separator|>
  121. [121]
    The ethics of research on deep brain stimulation for depression ...
    Jul 19, 2012 · We assessed 31 DBS research participants with the MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR), a well-validated ...
  122. [122]
    Mental capacity, legal competence and consent to treatment - PMC
    Deciding whether someone is legally competent to make decisions regarding their own treatment requires an assessment of their mental capacity.
  123. [123]
    Informed Consent in Deep Brain Stimulation – Ethical ... - Frontiers
    The cognitive based approach of capacity assessment in psychiatry: a philosophical critique of the MacCAT-T. ... Deep brain stimulation for psychiatric disorders.
  124. [124]
    Informed Consent and the Capacity for Voluntarism - Psychiatry Online
    The author suggests that voluntarism encompasses an individual's ability to act in accordance with one's authentic sense of what is good, right, and best.
  125. [125]
    Chapter 18 - Ethical Challenges in Psychosurgery: A New Start or ...
    A number of key ethical issues require attention, such as the design of studies, assessment of evidence, consent, management of conflicts of interest, and ...<|separator|>
  126. [126]
    Deep brain stimulation and revising the Mental Health Act
    Under the current Mental Health Act of England and Wales, it is lawful to perform deep brain stimulation in the absence of consent and independent approval.
  127. [127]
    Creating a thoughtful policy for proxy consent |… - Clinician.com
    The proxy also cannot give permission for psychosurgery, a point that Kim says might raise issues with some psychiatric research. He notes that currently ...
  128. [128]
    Proxy consent: moral authority misconceived - PMC - PubMed Central
    There is a substantially important ethical question surrounding proxy consent, as to whether the proxy should have the moral authority to make treatment ...Missing: psychosurgery | Show results with:psychosurgery
  129. [129]
    Psychosurgery Complications and Outcomes - News-Medical
    They reported that the efficacy was over 50% when the cases performed after the 1970s were studied, and that the incidence of psychological adverse effects was ...
  130. [130]
    Ethics of deep brain stimulation for neuropsychiatric disorders
    Aug 26, 2024 · This paper explores the clinical efficacy and ethical considerations of DBS in treating these disorders.
  131. [131]
    Clinical Ethics in the Context of Deep Brain Stimulation for ...
    Sep 25, 2017 · Several ethically complex and challenging questions arise in the context of treating patients with movement disorders on a Deep Brain ...Abstract · Introduction · Ethics in the Context of DBS... · Conclusion
  132. [132]
    Ethical considerations in closed loop deep brain stimulation
    Ethical considerations in closed-loop DBS revolve around five key principles: 1) risk/benefit analysis; 2) inclusion and exclusion criteria; 3) respect for ...
  133. [133]
    Contemporary psychosurgery and a look to the future in
    In this review, the definition of psychosurgery, patient selection criteria, and anatomical and physiological rationales for cingulotomy, subcaudate tractotomy, ...<|separator|>
  134. [134]
    Psychosurgery is back. But these are not the lobotomies of the past
    Jul 15, 2025 · Psychosurgery's revival has unnerved critics who remain unconvinced that science can point to a specific neural circuit or clump of neurons ...
  135. [135]
    Neuromodulation, free will and determinism - ScienceDirect.com
    In this article I will explore societal reluctance towards neuromodulation by considering the earlier debate over psychosurgery.
  136. [136]
    Deep Brain Stimulation in the Media: Over-Optimistic Portrayals Call ...
    Deep brain stimulation (DBS) is optimistically portrayed in contemporary media. This already happened with psychosurgery during the first half of the 20th ce ...Missing: modern | Show results with:modern
  137. [137]
    Scientific and Ethical Issues Related to Deep Brain Stimulation for ...
    Deep brain stimulation performed for compassionate or humanitarian use in single or small groups of patients should not be exempted from independent ethical ...
  138. [138]
    Psychiatric neurosurgery in the 21st century - PubMed Central
    The major advantage of DBS over lesion-based surgery is that if it does not work the hardware can be turned off and removed. In the longer term, stimulation ...
  139. [139]
    A prospective international multi-center study on safety and efficacy ...
    Oct 29, 2019 · In conclusion, DBS for severe treatment-resistant OCD patients reduced the severity of obsessive-compulsive symptoms by an average of 40%, with ...
  140. [140]
    Neuromodulation Strategies for the Treatment of Depression
    Dec 2, 2021 · The authors review the history and current state of neuromodulation for psychiatric illness and specifically focus on these approaches as a treatment for ...
  141. [141]
    Deep Brain Stimulation for Intractable Obsessive-Compulsive ...
    Jan 25, 2022 · The use of DBS to treat OCD and treatment-resistant depression is continuing to develop and could greatly affect the lives of patients with ...
  142. [142]
    Efficacy of deep brain stimulation for treatment-resistant obsessive ...
    Sep 20, 2022 · A strong evidence base supports DBS for TROCD in relieving both OCD and comorbid depression symptoms in appropriately selected patients.
  143. [143]
    A systematic review of focused ultrasound for psychiatric disorders
    Bilateral anterior capsulotomy resulted in a full responder rate of 67% (≥ 35% reduction in the Yale-Brown Obsessive-Compulsive Scale score) and 33% (≥ 50% ...
  144. [144]
    Stereotactic Cingulotomy and Capsulotomy - Aetna
    Aetna considers stereotactic cingulotomy medically necessary when it is used as a last resort to provide pain relief for members with terminal cancer pain.
  145. [145]
    Ventral targeted anterior capsulotomy for treatment-resistant ...
    Apr 1, 2024 · Ablative surgery using bilateral anterior capsulotomy (BAC) is an option for treatment resistant depression (TRD) and obsessive-compulsive disorder (TROCD).
  146. [146]
    Contemporary Role of Stereotactic Radiosurgery for Psychiatric ...
    [43] These studies confirmed the efficacy of capsulotomy for OCD, whereas cingulotomy appears less effective for patients with OCD. In a meta-analysis of ...<|separator|>
  147. [147]
    Predicting response to psychiatric surgery: a systematic review of ...
    Psychiatric surgery, including deep brain stimulation and stereotactic ablation, is an important treatment option in severe refractory psychiatric illness.
  148. [148]
    Shaping the Future of Psychiatric Neurosurgery: From Connectomic ...
    This manuscript reviews the current techniques, including lesion-based procedures and DBS, and explores their mechanisms of action, from synaptic plasticity to ...
  149. [149]
    Psychosurgery Evolves Into New Neurosurgery Approaches
    More than 50 years after indiscriminate use of prefrontal lobotomy gave psychosurgery a bad name, some psychiatrists are cautiously experimenting in ...Missing: modern | Show results with:modern
  150. [150]
    Future directions in psychiatric neurosurgery - ScienceDirect.com
    We present our strengths, weaknesses, opportunities, and threats analyses of the current state of psychiatric neurosurgery.